Koyfin Home > Directory > Health Care > Abeona Therapeutics > EBIT

Abeona Therapeutics EBIT Chart (ABEO)

Abeona Therapeutics annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Abeona Therapeutics EBIT for the quarter ending June 06, 2020 was $-12m a -41.41% increase of 5m year over year
  • Abeona Therapeutics EBIT for the last 12 months ending June 06, 2020 was $-62m a -27.25% increase of 17m year over year
  • Abeona Therapeutics Annual EBIT for 2019 was $-77m a 24.55% decrease of -19m from 2018
  • Abeona Therapeutics Annual EBIT for 2018 was $-58m a 52.14% decrease of -30m from 2017
  • Abeona Therapeutics Annual EBIT for 2017 was $-28m a 14.21% decrease of -4m from 2016
Other Income Statement Metrics:
  • Abeona Therapeutics EBITDA for the quarter ending September 09, 2018 was $-16m a 47.57% decrease of -8m year over year
  • Abeona Therapeutics Net Income for the quarter ending September 09, 2018 was $-16m a 48.54% decrease of -8m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO EBIT Data

06/2020$-12m
03/2020$-15m
12/2019$-16m
09/2019$-18m
06/2019$-24m
03/2019$-19m
12/2018$-18m
09/2018$-17m
06/2018$-13m
03/2018$-11m

Annual ABEO EBIT Data

2019$-77m
2018$-58m
2017$-28m
2016$-24m
2015$-19m
2014$-3m
2013$-4m
2012$-4m
2011$-8m
2010$-8m